Skip to content

RxSight, Inc. RXST Earnings yield

Earnings yield at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
3.6%-1.9pp
LENSAR, Inc. logo
LENSAR, Inc.LNSR
41.1%+28.3pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-15.8%-0.7pp
Precision Optics Corporation logo
Precision Optics CorporationPOCI
-10.3%-3.1pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.9%-1.2pp
Glaukos logo
GlaukosGKOS
-3%+1.7pp

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Calculated from RxSight, Inc.’s reported figures.

Based on trailing twelve months.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s earnings yield?
RxSight, Inc. (RXST) reported earnings yield of -18.3% in Q1 2026.
How has RxSight, Inc.'s earnings yield changed year-over-year?
RxSight, Inc.'s earnings yield decreased by 606.6% year-over-year, from -2.6% to -18.3%.
What is the long-term trend for RxSight, Inc.'s earnings yield?
Over 4 years (2021 to 2025), RxSight, Inc.'s earnings yield has grown at a -12.9% compound annual growth rate (CAGR), from -15.8% to -9.1%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.